www.fiercebiotech.com Open in urlscan Pro
104.18.0.205  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Webinar


SUPPORTING CLINICAL TRIALS WITH EARLY DETECTION BIOMARKER TESTING

Oct 1, 2024 11:00am ET
60 minutes


The clinical trial landscape continues to evolve at a rapid pace. New biomarker
detection technologies are driving breakthroughs to earlier discoveries and more
sensitive diagnostics. With early detection, biomarker testing research can
advance disease understanding and management in areas of care such as neurology,
oncology, immunology, cardiology, and infectious disease.

Join this webinar to:

 * Learn solutions to demanding clinical timelines
 * Explore cutting-edge biomarker technologies and their impact on clinical
   trials
 * Gain insights on leveraging biomarkers to advance disease understanding and
   management


SPEAKERS


MINGWEI ZHAO, PH.D.

Sr. Director of Accelerator Services
Quanterix

Mingwei Zhao is an expert in immunoassay development and biomarker research. He
began his career at Harvard University, focusing on gene expression and immune
responses. At Quanterix Corporation, he advanced Simoa technology and developed
ultrasensitive immunoassays. Now, as Senior Director of Lab Services, he
oversees custom assay development and manages external relationships. Zhao holds
a Bachelor's in Biology from Wuhan University and a Ph.D. in Molecular Biology
and Biochemistry from the Chinese Academy of Sciences.


REGISTER HERE!

Already registered? Click here to login.
Date/Time:
Oct 1, 2024 11:00am ET
Duration:
60 minutes

 * Connect
   
   * The Team
   * Advertise
 * Join Us
   
   * Newsletters
   * Resources
   * RSS Feeds
 * Our Brands
   
   * Fierce Pharma
   * Fierce Biotech
   * Fierce Healthcare
 * Our Events
   
   * Life Sciences Events

©2024 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings